Decreased Levels of Circulating IL17-Producing CD161+CCR6+ T Cells Are Associated with Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  van der Waart, Anniek B ^a   van der Velden, Walter J F M ^a   van Halteren, Astrid G S ^b   Leenders, Marij J L G ^a   Feuth, Ton ^a   Blijlevens, Nicole M A ^a   van der Voort, Robbert ^a   Dolstra, Harry ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD161 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GAMMA INTERFERON; IDARUBICIN; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MULTIDRUG RESISTANCE PROTEIN 1;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; CD161+CCR6+ T CELL; CD161+CD4+ T CELL; CD161+CD8+ T CELL; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE REDUCTION; DRUG TRANSPORT; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; T LYMPHOCYTE;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CCL20; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PHENOTYPE; RECEPTORS, CCR6; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84870737851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050896     Document Type: Article

References (46)

1. Ferrara JL, Levine JE, Reddy P, Holler E, (2009) Graft-versus-host disease. Lancet 373: 1550-1561.
2. Hill GR, Teshima T, Gerbitz A, Pan L, Cooke KR, et al. (1999) Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest 104: 459-467.
3. Socie G, Blazar BR, (2009) Acute graft-versus-host disease: from the bench to the bedside. Blood 114: 4327-4336.
4. Shlomchik WD, (2007) Graft-versus-host disease. Nat Rev Immunol 7: 340-352.
5. Ferrara JL, Reddy P, (2006) Pathophysiology of graft-versus-host disease. Semin Hematol 43: 3-10.
6. Zeis M, Uharek L, Hartung G, Glass B, Steinmann J, et al. (2001) Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice. Hematol J 2: 136-144.
7. Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M, (2000) Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 105: 1289-1298.
8. Ersvaer E, Melve GK, Bruserud O, (2011) Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation? Cancer Immunol Immunother 60: 1669-1681.
9. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, et al. (2009) In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 113: 1365-1374.
10. Yi T, Chen Y, Wang L, Du G, Huang D, et al. (2009) Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 114: 3101-3112.
11. Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, et al. (2009) IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 113: 945-952.
12. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, et al. (2008) Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 112: 2101-2110.
13. Broady R, Yu J, Chow V, Tantiworawit A, Kang C, et al. (2010) Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood 116: 5748-5751.
14. Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, et al. (2009) Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 88: 1261-1272.
15. Ratajczak P, Janin A, Peffault de LR, Leboeuf C, Desveaux A, et al. (2010) Th17/Treg ratio in human graft-versus-host disease. Blood 116: 1165-1171.
16. Bossard C, Malard F, Arbez J, Chevallier P, Guillaume T, et al. (2012) Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia.
17. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, et al. (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 107: 14751-14756.
18. Cosmi L, De PR, Santarlasci V, Maggi L, Capone M, et al. (2008) Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 205: 1903-1916.
19. Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, et al. (2010) CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 40: 2174-2181.
20. Lanier LL, Chang C, Phillips JH, (1994) Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153: 2417-2428.
21. Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, et al. (2005) Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 175: 7791-7795.
22. Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, et al. (2008) PILAR is a novel modulator of human T-cell expansion. Blood 112: 1259-1268.
23. Poggi A, Costa P, Zocchi MR, Moretta L, (1997) NKRP1A molecule is involved in transendothelial migration of CD4+ human T lymphocytes. Immunol Lett 57: 121-123.
24. Poggi A, Zocchi MR, Costa P, Ferrero E, Borsellino G, et al. (1999) IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol 162: 4349-4354.
25. Annibali V, Ristori G, Angelini DF, Serafini B, Mechelli R, et al. (2011) CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis. Brain 134: 542-554.
26. Turtle CJ, Delrow J, Joslyn RC, Swanson HM, Basom R, et al. (2011) Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161hi CD8{alpha}+ semi-invariant T cells. Blood 118: 2752-2762.
27. Northfield JW, Kasprowicz V, Lucas M, Kersting N, Bengsch B, et al. (2008) CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 47: 396-406.
28. Mitsuo A, Morimoto S, Nakiri Y, Suzuki J, Kaneko H, et al. (2006) Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases. Rheumatology (Oxford) 45: 1477-1484.
29. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, et al. (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117: 1250-1259.
30. Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, et al. (2010) Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 107: 3006-3011.
31. Takahashi T, Jbakhsh-Jones S, Strober S, (2006) Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176: 211-216.
32. Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR, (2009) A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 31: 834-844.
33. Broen K, van der Waart AB, Greupink-Draaisma A, Metzig J, Feuth T, et al. (2011) Polymorphisms in CCR6 Are Associated with Chronic Graft-versus-Host Disease and Invasive Fungal Disease in Matched-Related Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 17: 1443-1449.
34. Schutyser E, Struyf S, Van DJ, (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14: 409-426.
35. Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, et al. (2010) Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 151: 5468-5476.
36. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, et al. (2002) Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 11: 135-142.
37. Schaap N, Schattenberg A, Bar B, Preijers F, Kemenade W, et al. (2001) Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions. Leukemia 15: 1339-1346.
38. Eissens DN, Schaap NP, Preijers FW, Dolstra H, Van CB, et al. (2010) CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A. Leukemia 24: 583-591.
39. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, et al. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15: 825-828.
40. Lee SJ, Vogelsang G, Flowers ME, (2003) Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9: 215-233.
41. Overes IM, de Rijke B, van Horssen-Zoetbrood A, Fredrix H, de Graaf AO, et al. (2008) Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis. Br J Haematol 141: 799-807.
42. Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn PC, et al. (2003) Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 197: 1385-1390.
43. Choudhuri S, Klaassen CD, (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 25: 231-259.
44. Hendriks MP, Blijlevens NM, Schattenberg AV, Burger DM, Donnelly JP, (2006) Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients. Bone Marrow Transplant 38: 521-525.
45. Mohty M, Gaugler B, (2008) Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation. Cytokine Growth Factor Rev 19: 53-63.
46. Welniak LA, Blazar BR, Murphy WJ, (2007) Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 25: 139-170.